Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)
China · Delayed Price · Currency is CNY 16.59
+0.15 (0.91%)
At close: Aug 3, 2026
Huaxia Eye Hospital Group Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 4,196 | 4,139 | 4,027 | 4,013 | 3,233 | 3,064 |
Revenue Growth | 1.31% | 2.79% | 0.34% | 24.12% | 5.51% | 21.86% |
Gross Profit Gross Profit Growth | 1,822 | 1,783 | 1,768 | 1,958 | 1,546 | 1,403 |
Operating Income Operating Income Growth | 633.21 | 615.23 | 594.57 | 878.8 | 724.3 | 649.04 |
Net Income Net Income Growth | 462.64 | 440.65 | 428.64 | 665.93 | 513.82 | 454.92 |
Earnings Per Share EPS Growth | 0.55 | 0.53 | 0.51 | 0.79 | 0.67 | 0.61 |
EPS Growth | 10.19% | 3.92% | -35.44% | 17.91% | 10.43% | 35.82% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 3,894 | 3,728 | 4,158 | 4,240 | 4,143 | 953.42 |
Total Debt Total Debt Growth | 1,082 | 1,139 | 975.6 | 736.45 | 720.01 | 657.91 |
Net Cash (Debt) Net Cash Growth | 2,813 | 2,589 | 3,182 | 3,503 | 3,423 | 295.51 |
Net Cash Growth | -5.53% | -18.64% | -9.17% | 2.35% | 1058.22% | -41.52% |
Net Cash Per Share Net Cash Per Share Growth | 3.36 | 3.11 | 3.79 | 4.16 | 4.46 | 0.39 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 943.26 | 867.58 | 820.3 | 961.24 | 769.98 | 798.02 |
Capital Expenditures CapEx Growth | -205.53 | -231.99 | -279.59 | -448.43 | -235.31 | -173.63 |
Free Cash Flow Free Cash Flow Growth | 737.73 | 635.59 | 540.71 | 512.81 | 534.68 | 624.38 |
Free Cash Flow Growth | 20.48% | 17.55% | 5.44% | -4.09% | -14.37% | 46.11% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 43.41% | 43.07% | 43.90% | 48.80% | 47.83% | 45.79% |
Operating Margin | 15.09% | 14.86% | 14.77% | 21.90% | 22.40% | 21.18% |
Pretax Margin | 14.26% | 13.86% | 13.98% | 21.29% | 20.22% | 19.00% |
Profit Margin | 11.03% | 10.65% | 10.64% | 16.59% | 15.89% | 14.85% |
FCF Margin | 17.58% | 15.36% | 13.43% | 12.78% | 16.54% | 20.38% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.260 | 0.260 | 0.220 | 0.110 | 0.187 |
Dividend Per Share Growth | 18.18% | 18.18% | 100.00% | -41.08% | - |
Dividend Yield | 1.58% | 1.46% | 1.19% | 0.35% | 0.40% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 29.78 | 33.97 | 37.02 | 40.48 | 79.68 | - |
Forward PE | 26.10 | 29.97 | 20.33 | 34.32 | - | - |
P/FCF Ratio | 18.55 | 23.55 | 29.35 | 52.56 | 76.57 | - |
PS Ratio | 3.26 | 3.62 | 3.94 | 6.72 | 12.66 | - |